Finance | FROUSA Media

Google DeepMind has grand ambitions to ‘cure all diseases’ with AI. Now, it’s gearing up for its first human trials

July 6, 2025

Alphabet’s secretive drug discovery arm, Isomorphic Labs, is getting ready to start testing its AI-designed drugs in humans, Colin Murdoch, Isomorphic Labs president and...

Crayola’s now-CEO leaned in to automation when everyone else was offshoring and now he’s reaping the rewards

July 6, 2025

Two decades ago, the name of the game in U.S. manufacturing was offshoring. Just as China was entering the World Trade Organization and ramping...

At Hewlett Packard Enterprise, CEO Antonio Neri is negotiating with an activist investor with a history of forcing out chief executives

July 6, 2025

It was first publicly reported in April that the activist investor group Elliott Management had taken a $1.5 billion stake in Hewlett Packard Enterprise...

Why EchoStar Rocketed 56.2% in June | The Motley Fool

July 6, 2025

The CEO of one of the largest office maintenance firms in America says employers are changing their workspaces in 4 key ways

July 6, 2025

Scott Salmirs has a unique view of the RTO tug of war between workers and bosses that has taken over American offices over the...

Could Investing $10,000 in Coca-Cola Make You a Millionaire? | The Motley Fool

July 6, 2025

Millions of Gen Z are jobless yet ghosting employers. Phone anxiety is to blame—and experts say voice notes are the cure

July 6, 2025

Rohit Prasad is one of the most influential figures at Amazon right now. He jumped from being Alexa’s head scientist to running its AI...

Should You Buy This AI Stock That Soared 800% Last Year and Has a $140 Billion Total Addressable Market? | The Motley Fool

July 6, 2025